FDA Adverse Event Injury Summary report: N

PINN LNR CON +4 10D 40IDX62OD

MDR report key: 6731195 · Received July 21, 2017

Report

Report Number
1818910-2017-21433
Event Type
Injury
Date Received
July 21, 2017
Date of Event
June 21, 2017
Report Date
June 21, 2017
Manufacturer
DEPUY ORTHOPAEDICS, INC. 1818910
Product Code
KWZ
UDI-DI
10603295012221
PMA / PMN Number
K071117
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. THE INFORMATION RECEIVED WILL BE RETAINED FOR POTENTIAL SERIES INVESTIGATIONS IF TRIGGERED BY TREND ANALYSIS, POST MARKET SURVEILLANCE, OR OTHER EVENTS WITHIN THE QUALITY SYSTEM. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 1

THE PATIENT WAS REVISED TO ADDRESS HIP DISLOCATION. IT WAS STATED THAT HIS HIP BROKE WHICH IMPLANTED THE SAME SURGEON ON THE SAME HOSPITAL. THE PATIENT'S INITIAL PINNACLE 62MM OD X 40MM ID +4 10 DEGREE CONSTRAINED LINER WAS REPLACED WITH A PINNACLE 62MM OD X 40MM ID +4 NEUTRAL CONSTRAINED LINER. THE INITIAL 40MM +5 BIOLOX DELTA TS FEMORAL HEAD WAS ALSO REPLACED WITH A MATCHING 40MM +5 BIOLOX DELTA TS FEMORAL HEAD. UPDATE JUL 19, 2017: ADDITIONAL INFORMATION. THAT THE PATIENT HAD A FRACTURED CONSTRAINED LINER. THIS COMPLAINT WAS UPDATED ON JUL 19, 2017.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
511237 PINN LNR CON +4 10D 40IDX62OD HIP ACETABULAR INSERT/LINER KWZ DEPUY ORTHOPAEDICS, INC. 1818910 751760 10603295012221

Patients

Seq Age Sex Outcome Treatment
1 64 YR Hospitalization| R